TIGIT and intrahepatic cholangiocarcinoma: For example, It has been reported that intrahepatic cholangiocarcinoma (CCA) could interact with regulatory T cells (Treg) through the ligand‐receptor (L‐R) pair of TIGIT‐PVR, leading to immunosuppression in intrahepatic CCA (ICC) [7, 8].